Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
STAR Protocols|September 1, 2024
ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1Magdalena Schwarzmüller, Alexandra TrkolaPlos Pathogens|September 19, 2019
HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11Cosima Zimmermann, Daniel Kowalewski, Liane Bauersfeld, et al.Cell Reports. Medicine|August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccinesMagdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.The Journal of Clinical Investigation|April 28, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody responseMaddalena Marconato, Irene A Abela, Anthony Hauser, et al.Mbio|January 25, 2024
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infectionIrene A Abela, Magdalena Schwarzmüller, Agne Ulyte, et al.The Journal of Infectious Diseases|January 16, 2024
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort StudyIrene A Abela, Anthony Hauser, Magdalena Schwarzmüller, et al.Nature Communications|November 19, 2021
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunityIrene A Abela, Chloé Pasin, Magdalena Schwarzmüller, et al.Medrxiv : the Preprint Server for Health Sciences|July 17, 2026
Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis BZijun Wang, Mary Tenuta, Han Ngoc Le, et al.Pageof 1